Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Saudi Arabia

- PMLiVE

How digital content helps HCPs curb opioid abuse through better prescribing decisions

The patient experience and possibly adherence is affected by the extent to which they feel their participation is valued

- PMLiVE

EU citizens are living longer, but not always in good health

Report finds huge inequalities between and within countries despite higher life expectancy

- PMLiVE

Sanofi launches ‘Highs & Lows’ diabetes awareness campaign

Highlights impact of emotional and psychological factors on effective self-management

- PMLiVE

Shire to focus rare disease R&D with new US facility

Cambridge, Massachusetts hub to drive firm’s push to become leading rare disease specialist

- PMLiVE

McCann Health and Langland lead Global Awards 2016 winners

Collect best global network and best agency awards for fifth consecutive year

Sanofi reception

FDA clears rival diabetes combos from Sanofi and Novo Nordisk

Xultophy set to launch in first half of 2017 while Soliqua is intended for January roll-out

- PMLiVE

GSK files first application for triple COPD therapy

Submits combo in the US one year early to coincide with EU marketing application

- PMLiVE

Gilead’s hepatitis B virus treatment set for European approval

CHMP also recommends diabetes drugs from Sanofi and Novo Nordisk

- PMLiVE

Charting a course for expansion

David Meek on Ipsen's strategic pillars and hopes in oncology

- PMLiVE

A rock and a hard place

When insurance companies exclude drugs from their coverage

- PMLiVE

Siemens’ healthcare unit to become standalone business

German technology firm plans to publicly list it as Siemens Healthineers

- PMLiVE

Pharma stocks rise after Donald Trump’s election win

But his exact healthcare and industry-focus remain uncertain

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links